Primaa
This MedTech company provides an AI-based platform for automated cancer diagnosis using image analysis and deep learning. The software detects cancer biomarkers to assist pathologists with case prioritization, triage, and personalized treatment guidance. Its primary products include tools specifically designed for breast cancer and dermatopathology, such as the CE-IVDR marked solution for skin cancer detection.
Visit websiteParis, France
Healthtech
MedTech
Digital Pathology
Artificial Intelligence
Funding summary
- Total raised
- €9.0M
- Funding rounds
- 2
Investors in Primaa
Investors on record for Primaa. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Primaa?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors